These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8327015)

  • 1. [The possibility of intestinal hemorrhage in long-term use of acenocoumarol; a cohort study].
    van der Meer FJ; Rosendaal FR
    Ned Tijdschr Geneeskd; 1993 Jun; 137(25):1267-8. PubMed ID: 8327015
    [No Abstract]   [Full Text] [Related]  

  • 2. [Submucous hematoma of the cecum under anticoagulant therapy].
    Jacques M; Desaive C
    J Chir (Paris); 1986 Mar; 123(3):186-7. PubMed ID: 3487548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intramural hematoma of the digestive tract from vitamin K antagonists].
    Costecalde M; Pradère B; Parent Y; Barret A; Gouzi JL; Gédéon A
    Ann Chir; 1984 Feb; 38(1):31-6. PubMed ID: 6608911
    [No Abstract]   [Full Text] [Related]  

  • 4. [Potentialization of the anticoagulant action of antivitamin K by thienylic acid].
    Grand A; Drouin B; Arche GJ
    Nouv Presse Med; 1977 Sep; 6(30):2691. PubMed ID: 302935
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serious haemorrhages linked to acenocoumarol in a rural area].
    Calvo Romero JM; Lima Rodríguez EM
    Aten Primaria; 2005 Apr; 35(6):331-2. PubMed ID: 15826524
    [No Abstract]   [Full Text] [Related]  

  • 6. [Digestive hemorrhage caused by excessive hypocoagulation induced by interaction of piroxicam and a vitamin K antagonist].
    Desprez D; Blanc P; Larrey D; Michel H
    Gastroenterol Clin Biol; 1992; 16(11):906-7. PubMed ID: 1483568
    [No Abstract]   [Full Text] [Related]  

  • 7. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potentiation of the effects of acenocoumarol by miconazole].
    Ponge T; Barrier J; Spreux A; Guillou B; Larousse C; Grolleau JY
    Therapie; 1982; 37(2):221-2. PubMed ID: 7112491
    [No Abstract]   [Full Text] [Related]  

  • 9. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ileus caused by the use of acenocoumarol].
    de Boer HH
    Ned Tijdschr Geneeskd; 1967 Apr; 111(15):675-8. PubMed ID: 6047044
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.
    Mark L; Marki-Zay J; Fodor L; Hajdara I; Paragh G; Katona A
    Kardiol Pol; 2006 Apr; 64(4):397-402; discussion 403-4. PubMed ID: 16699986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary hemorrhage caused by the interaction of acenocoumarin and sodium diclofenac].
    Cuadrado Gómez LM; Palau Beato E; Pérez Venegas J; Pérez Moro E
    Rev Clin Esp; 1987 Sep; 181(4):227-8. PubMed ID: 3671847
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rare complications of anticoagulant therapy].
    Földváry G; Fedor I; Kaló E
    Orv Hetil; 1969 Sep; 110(39):2283-5. PubMed ID: 5350578
    [No Abstract]   [Full Text] [Related]  

  • 15. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.
    Visser LE; Penning-van Beest FJ; Wilson JH; Vulto AG; Kasbergen AA; De Smet PA; Hofman A; Stricker BH
    Br J Clin Pharmacol; 2004 Apr; 57(4):522-4. PubMed ID: 15025752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ileus with the use of acenocoumarol].
    Logman WG
    Ned Tijdschr Geneeskd; 1967 Jun; 111(23):1056. PubMed ID: 6044083
    [No Abstract]   [Full Text] [Related]  

  • 17. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
    Mazokopakis EE; Vrentzos GE; Ganotakis ES
    Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation.
    Tàssies D; Freire C; Pijoan J; Maragall S; Monteagudo J; Ordinas A; Reverter JC
    Haematologica; 2002 Nov; 87(11):1185-91. PubMed ID: 12414349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtherapeutic oral anticoagulant therapy: frequency and risk factors.
    Rombouts EK; Rosendaal FR; van der Meer FJ
    Thromb Haemost; 2009 Mar; 101(3):552-6. PubMed ID: 19277419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.